KETOROLAC TROMETHAMINE INJECTION, USP

Juno Pharmaceuticals Corp.🇨🇦 Health Canada

Approval Id: bf163b5d75757dc0
Drug Approval Canada Name: KETOROLAC TROMETHAMINE INJECTION, USP
Product Name: KETOROLAC TROMETHAMINE INJECTION, USP
Status: Marketed
Status Date: 2021-07-27
Original Market Date: 2016-04-26
Din: 02443376
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intramuscular
Schedule: Prescription
Ahfs: 28:08.04.92
Atc Original: M01AB15 KETOROLAC
Atc Name: m 01 ab 15
Aig Number: 0121995002
Company Name: Juno Pharmaceuticals Corp.
Company Address: 402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7

KETOROLAC TROMETHAMINE

30 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bf163b5d75757dc0

Type

Standard